Medico-economic impact of robot-assisted lung segmentectomy: what is the cost of the learning curve?


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 25 06 2019
revised: 10 09 2019
accepted: 11 09 2019
pubmed: 13 10 2019
medline: 2 9 2020
entrez: 13 10 2019
Statut: ppublish

Résumé

The objective of this study was to assess the learning curve (LC) of robot-assisted lung segmentectomy and to evaluate hospital-related costs. We conducted a retrospective study of Robot-assisted thoracic surgery (RATS) segmentectomies performed by 1 surgeon during 5 years. Perioperative and medical device data were collected. The LC, based on operating time, was assessed by Cumulative SUM analysis and an exponential model. Cost of care was estimated using the French National Cost Study method. One hundred and two RATS segmentectomies were included. The LC was completed at ∼30 procedures according to both models without significant difference in patients' characteristics before or after the LC. Mean operative time decreased from 136 min [95% confidence intervals (CI) 124-149] for the first 30 procedures to 97 min (95% CI 88-107) for the last 30 procedures. Mean length of stay decreased non-significantly (P = 0.10 for linear trend) from 8.1 days (95% CI 6.1-11.0) to 6.2 days (95% CI 4.9-7.9). The overall costs for the last 30 procedures as compared with the first 30 did not significantly decrease in the primary economic analysis but significantly decreased (P = 0.02) by €1271 (95% CI -2688 to +108, P = 0.02 for linear trend) after exclusion of 1 outlier (hospitalization-related costs > €10 000). After exclusion of this outlier, costs related to EndoWrist® instruments significantly decreased by €-135 (95% CI -220 to -35, P = 0.004), whereas costs related to clips decreased non-significantly (P = 0.28). The LC was completed at ∼30 procedures. Inexperienced surgeons may have higher procedure costs, related to consumable medical devices and operating time.

Identifiants

pubmed: 31605110
pii: 5585951
doi: 10.1093/icvts/ivz246
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-262

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Constance Le Gac (C)

Department of Pharmacy, Rouen University Hospital, Rouen, France.

Henri Gondé (H)

Department of Pharmacy, UNIROUEN, Inserm U1234, Rouen University Hospital, Normandie University, Rouen, France.

André Gillibert (A)

Department of Biostatistics, Rouen University Hospital, Rouen, France.

Marc Laurent (M)

Department of Pharmacy, Rouen University Hospital, Rouen, France.

Jean Selim (J)

Department of Anesthesiology, UNIROUEN, Inserm U1096, Rouen University Hospital, Normandie University, Rouen, France.

Benjamin Bottet (B)

Department of General and Thoracic Surgery, Rouen University Hospital, Rouen, France.

Rémi Varin (R)

Department of Pharmacy, UNIROUEN, Inserm U1234, Rouen University Hospital, Normandie University, Rouen, France.

Jean-Marc Baste (JM)

Department of General and Thoracic Surgery, UNIROUEN, Inserm U1096, Rouen University Hospital, Normandie University, Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH